Shira Naomi Dinner – Grants — Northwestern Scholars

View Scopus Profile

Emailshira.dinnernorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active
12 Finished

12 results

Filter

Finished
Supportive Oncology Collaborative for Adolescents and Young Adults
Garcia, S. F., Dinner, S. N., Kircher, S. M. & Sanford, S. D.
Coleman Foundation, Inc.
1/1/20 → 12/31/22
Project: Research project
Prot #GO40800: A Phase Ib/II Study Evaluating the Safety and Efficacy of Idasanutlin in Combination with Cytarabine and Daunorubicin in Patients Newly Diagnosed with Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenanc
Dinner, S. N.
Covance Inc., Genentech, Inc.
9/24/19 → 9/24/22
Project: Research project
Prot #1101-HEM-101: A Phase 1 Dose Escalation, Multicenter, Open-label, Safety, Pharmacokinetic and Pharmacodynamic Study of FT-1101 in Patients with Relapsed or Refractory Hematologic Malignancies
Dinner, S. N.
Translational Drug Development, LLC, FORMA Therapeutics, Inc.
9/8/17 → 9/8/20
Project: Research project
Alliance for Clinical Trials in Oncology Operations Center
Dinner, S. N.
Brigham and Women's Hospital, National Cancer Institute
9/1/17 → 2/28/19
Project: Research project
Executive Officer Grant Agreement
Dinner, S. N.
Alliance Foundation Trials, LLC
9/1/17 → 8/31/19
Project: Research project
Prot #NU 16H06: A phase l clinical trial evaluating the combination of volasertib (Bl-6727) with vincristine sulfate liposomal injections (VSLI) in adult patients with relapsed/refractory acute lymphoblastic leukemia
Dinner, S. N.
National Comprehensive Cancer Network, Boehringer Ingelheim Pharmaceuticals, Inc.
8/24/16 → 8/24/20
Project: Research project
CCITLA Supplement - Dinner
Dinner, S. N.
National Cancer Institute
8/1/16 → 7/31/18
Project: Research project
Prot #FLX925-01: Phase 1/1b, First-in-Human, Dose-Escalation and Expansion Study of FLX925 Administered Orally to Subjects with Relapsed or Refractory Acute Myeloid Leukemia
Dinner, S. N.
Medpace, Inc., FLX Bio, Inc.
3/16/16 → 3/16/19
Project: Research project
Prot #015001: The ROCKET Study: A Phase 2, Single-arm, Multicenter Trial to Determine the Efficacy and Safety of JCAR015 in Adult Subjects with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Dinner, S. N.
Juno Therapeutics, Inc.
1/8/16 → 1/8/19
Project: Research project
Prot #CD-ON-CAT-8015-1053: A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia
Dinner, S. N.
PRA Health Sciences, MedImmune, LLC
11/14/14 → 12/30/19
Project: Research project
Prot #AC220-007: A Phase 3 Open-Label Randomized Study of Quizartinib (Ac220) Monotherapy versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-Line Treatment With or Without Hema
Dinner, S. N.
Novella Clinical, LLC, Ambit Biosciences Corporation
3/25/14 → 3/25/17
Project: Research project
Prot #MEI-005: A Phase II Simon Two-Stage Study of the Addition of Pracinostat to a Hypomethylating Agent (HMA) in Patients with Myelodysplastic Syndrome (MDS) Who Have Failed to Respond or Maintain a Response to the HMA Alone
Altman, J. K. & Dinner, S. N.
SCRI Development Innovations, LLC, MEI Pharma, Inc.
3/7/14 → 3/7/17
Project: Research project